Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
500 participants
INTERVENTIONAL
1995-04-01
2027-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MRI to Detect Breast Tumors in Women
NCT00003302
Magnetic Resonance Imaging in Patients With Breast Cancer
NCT00610181
Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening
NCT03495115
Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRI
NCT00695968
Comparison Study of Breast Computed Tomography (CT) With Magnetic Resonance Imaging (MRI)
NCT00957099
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Magnetic Resonance Imaging (MRI) of Breast Cancer
Contrast-enhanced magnetic resonance imaging (MRI) using the standard department of Radiology MRI screening procedures. The duration of scanning may be variable, but will not exceed 90 minutes.
MRI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Documented breast physical examination,
* Documented mammography within 3 months of the MR studies
* Palpable or mammographically-detected suspect breast lesions
* Women who have already undergone lumpectomy for breast cancer and have post-biopsy/post-radiation changes will be eligible if they have mammographically-detected or palpable breast abnormalities which are sufficiently suspicious to merit core needle or surgical biopsy.
Exclusion Criteria
* Able to complete the MR examination. Subjects will be interviewed by one of the investigators for the usual contraindications to
* MR contraindications including
* Pacemakers
* Metallic implants
* Severe claustrophobia
* Aneurysm clips
* Pregnancy
* Current lactation
* Other conditions precluding proximity to a strong magnetic field.
* Received an enhanced MR procedure within 48 hours,
* Iodinated contrast within six hours,
* Known sensitivity to MR contrast agents,
* Not likely to complete the study in full or
* Other clinical reason which would preclude participation in the protocol.
21 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
National Institutes of Health (NIH)
NIH
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruce L Daniel
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University School of Medicine
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13IB-0074
Identifier Type: OTHER
Identifier Source: secondary_id
75763
Identifier Type: OTHER
Identifier Source: secondary_id
BRSNSTU0004
Identifier Type: OTHER
Identifier Source: secondary_id
NCI-2024-01929
Identifier Type: REGISTRY
Identifier Source: secondary_id
IRB-10748
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.